3SBio (STU:83B) Institutional Ownership: 42.00% (As of Aug. 03, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

STU:83B 3SBio Inc STU:83B
88 GF Score
Price €1.78
GF Value €1.39
Valuation Modestly Overvalued
! 1 Warning Sign
View Full Analysis

What is 3SBio Institutional Ownership?

3SBio STU:83B -4.23% 88 Institutional Ownership is 42.00% as of Aug. 03, 2026. GuruFocus rates STU:83B with a GF Score™ of 88/100 and a GF Value™ of €1.39 (Modestly Overvalued). The stock has 1 warning sign investors should review.

Institutional ownership is the percentage of shares that are owned by institutions out of the total shares outstanding. As of today, 3SBio's institutional ownership is 42.00%.

Insider Ownership is the percentage of shares that are owned by company insiders relative to the total shares outstanding. As of today, 3SBio's Insider Ownership is 0.00%.

Float Percentage Of Total Shares Outstanding is the percentage of float shares relative to the total shares outstanding. As of today, 3SBio's Float Percentage Of Total Shares Outstanding is 0.00%.

3SBio Institutional Ownership Historical Data

* Premium members only.

The historical data trend for 3SBio's Institutional Ownership can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

3SBio Institutional Ownership Chart

3SBio Historical Data

The historical data trend for 3SBio can be seen below:

2025-09-30 2025-10-31 2025-11-30 2025-12-31 2026-01-31 2026-02-28 2026-03-31 2026-04-30 2026-05-31 2026-06-30
Institutional Ownership 39.36 39.17 39.80 41.33 41.31 41.18 41.48 41.76 41.73 42.00
STU:83B
88GF Score
3SBio Inc STU:83B
Institutional Ownership is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

3SBio Institutional Ownership Calculation

The percentage of shares that are owned by institutions out of the total shares outstanding.

What does a Institutional Ownership of 42.00% mean?
3SBio (STU:83B) has a Institutional Ownership of 42.00% as of Aug. 03, 2026. Institutional ownership equals the percent of shares owned by financial institutions relative to total shares. View historical data on 3SBio and its competitors.
Is 3SBio's Institutional Ownership too high?
3SBio's current Institutional Ownership is 42.00%. Overall, 3SBio has a GF Score™ of 88/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does 3SBio's Institutional Ownership compare to VRTX and REGN?
3SBio's Institutional Ownership of 42.00% can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Institutional Ownership for a Biotechnology company?
A good Institutional Ownership depends on the Biotechnology industry context. However, Institutional Ownership should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Institutional Ownership mean?
A high Institutional Ownership can signal that a stock is expensive relative to its fundamentals. Institutional ownership equals the percent of shares owned by financial institutions relative to total shares. View historical data on 3SBio and its competitors. 3SBio's current Institutional Ownership is 42.00%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is 3SBio stock overvalued right now?
Based on GuruFocus' analysis, 3SBio (STU:83B) is currently considered Modestly Overvalued. The stock's GF Value™ is €1.39, compared to a current price of €1.78 — trading 28.1% above its estimated fair value. The current Institutional Ownership is 42.00%. 3SBio's overall GF Score™ is 88/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Institutional Ownership calculated?
Institutional Ownership is calculated from a company's financial statements. For 3SBio (STU:83B), the current Institutional Ownership is 42.00% as of Aug. 03, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is 3SBio (STU:83B) Overvalued in 2026?

Based on GuruFocus' analysis, 3SBio stock appears to be overvalued. The current stock price of €1.78 is trading 28.1% above its estimated GF Value™ of €1.39. GuruFocus considers 3SBio to be Modestly Overvalued.

Key valuation signals for STU:83B:

  • Institutional Ownership: 42.00%
  • GF Value™: €1.39 vs. price of €1.78 (28.1% above fair value)
  • GF Score™: 88/100 with 1 warning sign

No single metric tells the full story. See the STU:83B stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

3SBio Business Description

Other Exchanges TRSBF:USA01530:Hong Kong
Address No. 3 A1, Road 10, Shenyang Economy and Technology Development Zone, Shenyang, CHN
3SBio Inc is an investment holding company. It is a primary biotechnology company. The company is principally engaged in the development, production, marketing and sale of biopharmaceutical products in the People's Republic of China. The group has only one operating segment. It has presence in Chinese mainland, USA, Other countries/regions. The majority of revenue comes from USA. The core commercialized products of the group include several bio-pharmaceutical drugs, namely, TPIAO, recombinant human erythropoietin (rhEPO) products EPIAO and SEPO, Yisaipu and Cipterbin, and a small molecule drug, Mandi series of minoxidil drugs.
88GF Score

Get the complete analysis for STU:83B

Institutional Ownership is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€1.78
Price
€1.39
GF Value